title: Ankylosing spondylitis and uveitis: overview.
abstract: The present article reviews the epidemiology, pathogenesis, clinical features, diagnosis, and treatment of ankylosing spondylitis and its association with ocular changes. The authors used the PubMed (MEDLINE), LILACS, and Ophthalmology Library databases. Ankylosing spondylitis is a chronic inflammatory disease that usually affects the axial skeleton and can progress to stiffness and progressive functional limitation. Ankylosing spondylitis usually begins around the second to third decade of life, preferentially in HLA-B27-positive white males. Its etiology and pathogenesis are not completely understood, and its diagnosis is difficult. Clinical control and treatment are frequently satisfactory. Acute anterior uveíte is the most common extra-articular manifestation, occurring in 20%-30% of the patients with ankylosing spondylitis. Approximately half of the acute anterior uveíte cases are associated with the presence of the HLA-B27 antigen. It can be the first manifestation of an undiagnosed rheumatic disease, usually having a good prognosis and appropriate response to treatment. In conclusion, for better assessment and treatment of patients with uveitis, ophthalmologists and rheumatologists should work together.
authors.affiliation: Faculdade de Medicina, Universidade de São Paulo, Brazil. ewazowzky@uol.com.br
authors.forename: Enéias Bezerra
authors.initials: EB
authors.lastname: Gouveia
authors.forename: Dório
authors.initials: D
authors.lastname: Elmann
authors.forename: Maira Saad de Ávila
authors.initials: MS
authors.lastname: Morales
mesh_terms: D015796:HLA-B27 Antigen / Q000276:immunology; D006801:Humans; D011379:Prognosis; D013167:Spondylitis, Ankylosing / Q000150:complications* / Q000175:diagnosis / Q000209:etiology / Q000276:immunology / Q000628:therapy; D014605:Uveitis / Q000175:diagnosis / Q000209:etiology* / Q000276:immunology / Q000628:therapy
chemical_list: D015796:HLA-B27 Antigen